Investment
Features
FeesSafety
Academy
More
Pluang+

Compare RUM Group Inc. Class A Common Stock (RUM) vs Twist Bioscience Corp (TWST) Price & Performance

RUM Group Inc. Class A Common StockTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

RUM Group Inc. Class A Common Stock vs Twist Bioscience Corp — how do they compare? RUM Group Inc. Class A Common Stock trades at $5.88 (market cap $2.42B), while Twist Bioscience Corp trades at $135.65 (market cap $9.82B). The key difference: Twist Bioscience Corp is far larger — about 4.1× RUM Group Inc. Class A Common Stock's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, RUM Group Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold RUM Group Inc. Class A Common Stock for 0 Days and Twist Bioscience Corp for 27 Days on average.

RUMTWST
Market Cap
$2.42B$9.82B
Volume
5,814,3492,115,226
Sector
MediaHealth
52-Week High
$10.23$205.00
52-Week Low
$4.67$25.45
Typical Hold Time
0 Days27 Days
Enterprise Value
$2.71B$9.75B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

RUM Group Inc. Class A Common Stock

No Aura AI signal available yet.

Twist Bioscience Corp

TWST trades at $151.33, down 0.35% today, near its consensus price target of $153.70. The stock shows a bullish technical signal despite recent earnings misses, with revenue growth improving from $204M in 2022 to $377M in 2025. However, profitability remains a challenge with a net income margin of -31.66% and negative cash flows. Recent news highlights its role in Eli Lilly's AI-driven drug discovery platform, fueling investor optimism in the healthtech sector.

The outlook balances strong revenue growth and AI partnerships against persistent losses and high valuation multiples. Investment appeal hinges on the company's ability to translate top-line expansion into profitability, with analyst consensus leaning bullish but execution risks remaining elevated for stockholders.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RUM
100% Buy0% Sell
Avg holding period · 0 Days
TWST
49% Buy51% Sell
Avg holding period · 27 Days

Top news

Latest headlines on both assets

About RUM Group Inc. Class A Common Stock

RUM Group Inc., formerly Rumble Inc., is a holding company operating two business units: Rumble, an online video-sharing platform, and Quake AI, a cloud computing and artificial-intelligence infrastructure business.

Read more on RUM →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST →